In 1999, Damalas et al. demonstrated that the overexpression of β-catenin induced the accumulation of transcriptionally active p53, which triggered an inhibitory p53 response in lung adenocarcinoma cells [115]. Here, TP53 is linked to lung adenocarcinoma.